医学
诊断优势比
荟萃分析
内科学
优势比
接收机工作特性
曲线下面积
背景(考古学)
心力衰竭
毛细管再灌注
置信区间
心脏病学
血压
生物
古生物学
作者
Matthias Jacquet‐Lagrèze,Aymeric Pernollet,Eduardo Kattan,Hafid Ait‐Oufella,Delphine Chesnel,Martin Ruste,Rémi Schweizer,Bernard Allaouchiche,Glenn Hernández,Jean-Luc Fellahi
出处
期刊:Critical Care
[Springer Nature]
日期:2023-12-02
卷期号:27 (1)
被引量:6
标识
DOI:10.1186/s13054-023-04751-9
摘要
Abstract Purpose Acute circulatory failure leads to tissue hypoperfusion. Capillary refill time (CRT) has been widely studied, but its predictive value remains debated. We conducted a meta-analysis to assess the ability of CRT to predict death or adverse events in a context at risk or confirmed acute circulatory failure in adults. Method MEDLINE, EMBASE, and Google scholar databases were screened for relevant studies. The pooled area under the ROC curve (AUC ROC), sensitivity, specificity, threshold, and diagnostic odds ratio using a random-effects model were determined. The primary analysis was the ability of abnormal CRT to predict death in patients with acute circulatory failure. Secondary analysis included the ability of CRT to predict death or adverse events in patients at risk or with confirmed acute circulatory failure, the comparison with lactate, and the identification of explanatory factors associated with better accuracy. Results A total of 60,656 patients in 23 studies were included. Concerning the primary analysis, the pooled AUC ROC of 13 studies was 0.66 (95%CI [0.59; 0.76]), and pooled sensitivity was 54% (95%CI [43; 64]). The pooled specificity was 72% (95%CI [55; 84]). The pooled diagnostic odds ratio was 3.4 (95%CI [1.4; 8.3]). Concerning the secondary analysis, the pooled AUC ROC of 23 studies was 0.69 (95%CI [0.65; 0.74]). The prognostic value of CRT compared to lactate was not significantly different. High-quality CRT was associated with a greater accuracy. Conclusion CRT poorly predicted death and adverse events in patients at risk or established acute circulatory failure. Its accuracy is greater when high-quality CRT measurement is performed.
科研通智能强力驱动
Strongly Powered by AbleSci AI